Why the study?
Cardiomyopathy in children is a leading cause of heart failure and transplantation, and while genetic testing increasingly informs diagnosis and management, understanding the clinical implications of variants of uncertain significance remains a major challenge.
Population
Pediatric patients with cardiomyopathy and myocarditis
Design
Review
Authors
Loading...
May inform genetic evaluation in pediatric cardiomyopathy; leaves open validation of shared pathways in cardioskeletal myopathies and myocarditis.
Genetic testing is increasingly recognized as standard of care for pediatric cardiomyopathy, highlighting common pathways in cardioskeletal myopathies and the role of genetics in myocarditis.
Lee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: